Literature DB >> 3263912

Recurrent ventricular tachycardia due to pentamidine-induced cardiotoxicity.

M R Bibler1, T C Chou, R J Toltzis, P A Wade.   

Abstract

Although pentamidine isethionate is effective in the treatment of Pneumocystis carinii pneumonia, it frequently causes serious adverse reactions. We report a case of reversible pentamidine-induced cardiotoxicity, characterized electrocardiographically by prolongation of the QT interval, T-wave inversion, and electrical alternans of the U-wave. In addition, the patient had repeated episodes of ventricular tachycardia that culminated in torsades de pointes. Our case re-emphasizes the need for close patient monitoring during pentamidine therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263912     DOI: 10.1378/chest.94.6.1303

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Pentamidine reduces hERG expression to prolong the QT interval.

Authors:  Jason S Cordes; Zhuoqian Sun; David B Lloyd; Jenifer A Bradley; Alan C Opsahl; Mark W Tengowski; Xian Chen; Jun Zhou
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 2.  Drug effects on the electrocardiogram. A review of their clinical importance.

Authors:  J D Symanski; L S Gettes
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

Review 3.  Pentamidine. A risk-benefit analysis.

Authors:  B Wispelwey; R Pearson
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

4.  The anti-protozoal drug pentamidine blocks KIR2.x-mediated inward rectifier current by entering the cytoplasmic pore region of the channel.

Authors:  T P de Boer; L Nalos; A Stary; B Kok; M J C Houtman; G Antoons; T A B van Veen; J D M Beekman; B L de Groot; T Opthof; M B Rook; M A Vos; M A G van der Heyden
Journal:  Br J Pharmacol       Date:  2010-02-24       Impact factor: 8.739

5.  Molecular determinants of pentamidine-induced hERG trafficking inhibition.

Authors:  Adrienne T Dennis; Lu Wang; Hanlin Wan; Drew Nassal; Isabelle Deschenes; Eckhard Ficker
Journal:  Mol Pharmacol       Date:  2011-11-01       Impact factor: 4.436

6.  Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance.

Authors:  Luigi X Cubeddu
Journal:  Curr Cardiol Rev       Date:  2009-08

Review 7.  QT prolongation with antimicrobial agents: understanding the significance.

Authors:  Robert C Owens
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Chronic pentamidine aerosol prophylaxis does not induce QT prolongation.

Authors:  C Thalhammer; J R Bogner; G Lohmöller
Journal:  Clin Investig       Date:  1993-04

9.  Inhibiting the clathrin-mediated endocytosis pathway rescues K(IR)2.1 downregulation by pentamidine.

Authors:  Rosanne Varkevisser; Marien J C Houtman; Maaike Waasdorp; Joyce C K Man; Raimond Heukers; Hiroki Takanari; Ralph G Tieland; Paul M P van Bergen En Henegouwen; Marc A Vos; Marcel A G van der Heyden
Journal:  Pflugers Arch       Date:  2012-11-29       Impact factor: 3.657

10.  Structure-activity relationships of pentamidine-affected ion channel trafficking and dofetilide mediated rescue.

Authors:  R Varkevisser; M J C Houtman; T Linder; K C G de Git; H D M Beekman; R R Tidwell; A P Ijzerman; A Stary-Weinzinger; M A Vos; M A G van der Heyden
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 9.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.